Opiate Prescribing Guidelines Following Hip Arthroscopy
How Many Opiates Should be Prescribed for Pain in Patients Undergoing Hip Arthroscopy?
1 other identifier
interventional
111
1 country
1
Brief Summary
The purpose of the study is to determine if opiates are required to achieve appropriate analgesia after hip arthroscopy in outpatient surgery. The investigators hypothesize that patients are frequently prescribed more opiates than are needed after surgery, resulting in excess medications that are at risk for misuse, diversion and contribution to the opioid epidemic
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2018
CompletedFirst Submitted
Initial submission to the registry
November 13, 2019
CompletedFirst Posted
Study publicly available on registry
November 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 8, 2020
CompletedResults Posted
Study results publicly available
August 27, 2020
CompletedOctober 5, 2020
September 1, 2020
1.7 years
November 13, 2019
July 29, 2020
September 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (19)
Numeric Pain Rating Scale (NPRS) Pain Scores
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
Baseline (pre-operative)
Numeric Pain Rating Scale (NPRS) Pain Scores
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
2 hours post-operative
Numeric Pain Rating Scale (NPRS) Pain Scores
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
24 hours post-operative
Numeric Pain Rating Scale (NPRS) Pain Scores
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
48 hours post-operative
Numeric Pain Rating Scale (NPRS) Pain Scores
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
7 days post-operative
Opiates Taken
Number of prescribed narcotic pills taken in the preceding time period
24 hours post-operative
Opiates Taken
Number of prescribed narcotic medication tablets taken in the preceding time period
48 hours post-operative
Opiates Taken
Number of prescribed narcotic medication tablets taken in the preceding time period
7 days post-operative
Opiates Taken
Number of prescribed narcotic medication tablets taken in the preceding time period
21 days post-operative
Opiates Remaining
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
24 hours post-operative
Opiates Remaining
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
48 hours post-operative
Opiates Remaining
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
7 days post-operative
Opiates Remaining
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
21 days post-operative
Date of Last Opiate Taken
Days following surgery that the most recent dose of narcotic medication was taken
21 days post-operative
Numeric Pain Rating Scale (NPRS) Pain Scores
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
21 days
Number of Participants Reporting Side Effects
As reported by patient. Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, itchiness, nausea/vomiting
24 hours postoperatively
Number of Participants Reporting Side Effects
As reported by patient. Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, nausea/vomiting
48 hours postoperatively
Number of Participants Reporting Side Effects
As reported by patient. Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, nausea/vomiting
7 days postoperatively
Number of Participants Reporting Side Effects
As reported by patient. Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, nausea/vomiting
21 days postoperatively
Study Arms (2)
Group 1 - Hip Arthroscopy
ACTIVE COMPARATORWill be prescribed 60 opiate tablets in addition to other routine post-operative pain medication regimens.
Group 2 - Hip Arthroscopy
ACTIVE COMPARATORWill be prescribed 30 opiate tablets in addition to other routine post-operative pain medication regimens.
Interventions
Will be prescribed 60 opiate tablets in addition to other routine post-operative pain medication regimens.
Will be prescribed 30 opiate tablets in addition to other routine post-operative pain medication regimens.
Eligibility Criteria
You may qualify if:
- All patients presenting to Northwestern Memorial Hospital (NMH) or to a Northwestern orthopaedic surgery faculty member's clinic undergoing hip arthroscopy
- years old or greater
- Ability to read and speak English
You may not qualify if:
- Revision surgery
- Oncologic etiology
- Arthroscopic hip surgery that involves procedures other than labral repair, acetabuloplasty, CAM-plasty, IT band windowing, Iliopsoas lengthening
- Patients with a current indication of narcotic use
- Individuals unable to provide informed consent:
- Prisoners
- Pregnant women
- Minors/Individuals under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University Department of Orthopaedic Surgery
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Melissa Shauver; Research Project Manager
- Organization
- Northwestern University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Orthopaedic Surgery
Study Record Dates
First Submitted
November 13, 2019
First Posted
November 19, 2019
Study Start
June 12, 2018
Primary Completion
February 21, 2020
Study Completion
July 8, 2020
Last Updated
October 5, 2020
Results First Posted
August 27, 2020
Record last verified: 2020-09